35 studies found for:    Open Studies | "Dengue"
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Immunodeficiency Virus
Interventions: Biological: CYD Dengue Vaccine;   Biological: Placebo (NaCl 0.9%) vaccine group
2 Recruiting Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine (5-dose formulation);   Biological: Placebo, NaCl 0.9%
3 Recruiting Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: NaCl + CYD Dengue Vaccine
4 Recruiting Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
5 Recruiting TDENV PIV and LAV Dengue Prime-boost Strategy
Condition: Dengue
Interventions: Biological: TDENV-LAV;   Biological: TDENV-PIV 4 µg + alum adjuvant
6 Not yet recruiting A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Condition: Dengue
Intervention: Procedure: Blood sample collection
7 Recruiting Ketotifen as a Treatment for Vascular Leakage During Dengue Fever
Conditions: Dengue Fever;   Pleural Effusion
Interventions: Drug: Ketotifen;   Drug: Placebo
8 Recruiting International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
Condition: Dengue Fever
Intervention: Other: Observation
9 Recruiting The Use of Biomarkers in Predicting Dengue Outcome
Condition: Dengue
Intervention:
10 Unknown  Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
11 Recruiting Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain
Condition: Dengue
Intervention: Biological: Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)
12 Recruiting An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Condition: Dengue
Interventions: Procedure: Blood sample collection;   Other: Data collection
13 Recruiting Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: rDEN3∆30;   Biological: Placebo
14 Recruiting Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
Condition: Dengue
Interventions: Biological: Recombinant live attenuated trivalent dengue vaccine;   Biological: Placebo;   Biological: rDEN2Δ30-7169 vaccine
15 Not yet recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
16 Not yet recruiting Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
Condition: Dengue Fever
Interventions: Drug: Celgosivir;   Drug: Modipafant 50mg;   Drug: Placebo;   Drug: Modipafant 100mg
17 Unknown  Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
18 Unknown  Dengue Seroprevalence Study in Blood Donors in the French West Indies
Conditions: Blood Donors;   Dengue
Intervention: Other: Biological sample collection
19 Not yet recruiting Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis
Condition: Dengue
Intervention: Device: SaniSal Oral Fluid Collector
20 Recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Interventions: Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years